Giving Compass' Take:

• Democratic Representative Anna Eshoo has stated that she wants to be fair and "examine the entirety of the issue" when it comes to drug companies and policies. 

• How can our government insure that affordable access is granted to those in need however also monitoring and keeping tabs on our opioid crisis? 

Here's an article on the Health and Human Services Secretary pushing congress to lower drug prices. 

A key Democrat on drug pricing issues said Wednesday that she does not want to “punish” the pharmaceutical industry, striking a softer tone than many other Democrats do on the issue.

Rep. Anna Eshoo (D-Calif.), the new chairwoman of the powerful Energy and Commerce health subcommittee, has received criticism from some drug pricing advocates that she is too close to the pharmaceutical industry.

Asked about the criticism on Wednesday and if she would be tough on drug companies, Eshoo told reporters, “I'm going to be fair. I'm not out to punish or to do things out of vengeance.”

Read the full article about examining policies and laws on drug companies by Peter Sullivan at The Hill